Search research articles
Contact Us
Filters
Showing results (181-190 of 187) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 187 results.
The American Journal of Cardiology
|
May 4, 2024
Association Between Vegetation Size and Outcome in the Partial Oral Antibiotic Endocarditis Treatment Trial
Rasmus Carter-Storch, Mia Marie Pries-Heje, Jonas A Povlsen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 30, 2025
Target attainment of benzylpenicillin in patients with infective endocarditis
Magnus Bock, Johan G C Van Hasselt, Kurt Fuursted, et al.
European Heart Journal
|
May 31, 2019
Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study
Lauge Østergaard, Niels Eske Bruun, Marianne Voldstedlund, et al.
The New England Journal of Medicine
|
February 9, 2022
Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial
Mia M Pries-Heje, Christoffer Wiingaard, Nikolaj Ihlemann, et al.
The Journal of Antimicrobial Chemotherapy
|
October 12, 2023
Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis
Magnus Bock, Johan G C Van Hasselt, Franziska Schwartz, et al.
Journal of Psychosomatic Research
|
January 25, 2022
The impact of partial-oral endocarditis treatment on anxiety and depression in the POET trial
Johan S Bundgaard, Kasper Iversen, Mia Pries-Heje, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 22, 2023
Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy
Magnus Bock, Anna Marie Theut, Johan G C van Hasselt, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 187) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 187 results.
The American Journal of Cardiology
|
May 4, 2024
Association Between Vegetation Size and Outcome in the Partial Oral Antibiotic Endocarditis Treatment Trial
Rasmus Carter-Storch, Mia Marie Pries-Heje, Jonas A Povlsen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 30, 2025
Target attainment of benzylpenicillin in patients with infective endocarditis
Magnus Bock, Johan G C Van Hasselt, Kurt Fuursted, et al.
European Heart Journal
|
May 31, 2019
Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study
Lauge Østergaard, Niels Eske Bruun, Marianne Voldstedlund, et al.
The New England Journal of Medicine
|
February 9, 2022
Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial
Mia M Pries-Heje, Christoffer Wiingaard, Nikolaj Ihlemann, et al.
The Journal of Antimicrobial Chemotherapy
|
October 12, 2023
Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis
Magnus Bock, Johan G C Van Hasselt, Franziska Schwartz, et al.
Journal of Psychosomatic Research
|
January 25, 2022
The impact of partial-oral endocarditis treatment on anxiety and depression in the POET trial
Johan S Bundgaard, Kasper Iversen, Mia Pries-Heje, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 22, 2023
Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy
Magnus Bock, Anna Marie Theut, Johan G C van Hasselt, et al.
Page
of 19